Previous 10 | Next 10 |
CLEVELAND , Dec. 17, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the first MRIdian MRI-guided radiotherapy system in the United Kingdom (UK) – located at GenesisCare Oxford – has begun patient treatments. MRIdian combines high definition MRI...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Larry Culp is a Builder of Corporations, Not a Caretaker We've all heard the nostrum "The best defense is a good offense". The best way for General Electric (GE) to dig out of its liabilities is to change the growth profile and boost cash flow. The opportunity to gather revenue-generating ...
CNS Pharmaceuticals (NASDAQ: CNSP ) initiated with Speculative Buy rating at Benchmark. More news on: CNS Pharmaceuticals, Inc., Proteostasis Therapeutics, Inc., STAAR Surgical Company, Healthcare stocks news, Stocks on the move, , Read more ...
ViewRay (NASDAQ: VRAY ) has priced its public offering of 41,550,000 common shares at $3.13 per share, for gross proceeds of ~$130.1M. More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Tuesday was a bad day on Wall Street, as major benchmarks fell sharply on news from the White House regarding trade. President Trump said that it might be better for the U.S. not to expect a trade deal with China until after the 2020 presidential election, throwing cold water on recent hopes tha...
Gainers: Audentes Therapeutics (NASDAQ: BOLD ) +105% . More news on: Audentes Therapeutics, Inc., ViewRay, Inc., Outlook Therapeutics, Inc., Stocks on the move, Read more ...
In response to announcing collaboration deals with Elekta and Medtronic (NYSE: MDT) as well as a common stock offering, shares of ViewRay (NASDAQ: VRAY) , a seller of innovative radiation therapy machines, jumped 31% as of 11:15 a.m. EST on Tuesday. Here are the key terms of the dea...
Audentes Therapeutics (NASDAQ: BOLD ) +105% as Astellas Pharma to buy Audentes Therapeutics for $60/share. More news on: Audentes Therapeutics, Inc., ViewRay, Inc., uniQure N.V., Stocks on the move, Read more ...
Are Any Of These Penny Stocks On Your Watch List Right Now? When it comes to penny stocks to watch , timing can play a role in your strategy. Certain corporate events, disclosure filings, and even industry news can act as significant catalysts for stocks to break out. But then again, some com...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...